UBS’s sale of Forex investment products under investigation


The securities arbitration law firm Dimond Kaplan & Rothstein, P.A. in an official release states they are investigating UBS Group AG (USA) (NYSE:UBS) UBS Financial Services arm relating to recommendations and sales of currency and foreign exchange products, including the UBS V10 Enhanced FX Carry Strategy. The UBS V10 product was pitched to individual and institutional investors, including hedge funds and pension funds, as a high-yielding foreign-exchange investment that used computer algorithms to minimize the risk of losses in periods of volatility. The product has not performed as advertised, however, and investors have lost a significant amount of money.

The U.S. Justice Department is investigating whether UBS misrepresented how currency transactions were priced within UBS’s V10 product. This scrutiny is part of regulators’ wider investigation into manipulation in the foreign-exchange market. According to one news source, Barclays Plc also apparently sold a similarly problematic foreign-exchange product that involved an “optimized currency carry strategy.”

The regulatory scrutiny that UBS faces, comes on the heels of hundreds of FINRA arbitration claims and several class action lawsuits that UBS has faced over the past several years and currently faces regarding billions of dollars in losses that investors have suffered in UBS’s risky UBS Puerto Rico bond funds and in risky Lehman Brothers structured products that UBS sold.

Dimond Kaplan & Rothstein, P.A. has represented investors in claims against UBS involving complex foreign currency carry trade strategies. If you lost money in the UBS V10 product or in other foreign-currency transactions, including those involving the Swiss Franc or the Japanese Yen, you can visit Dimond Kaplan & Rothstein, P.A. online by clicking here.

Related News

arrow

UBS’s sale of Forex investment products under investigation

19

Send this to a friend